Eiichi Suematsu Selected Research

Eiichi Suematsu Research Topics

Disease

21	Rheumatoid Arthritis 04/2022 - 04/2008
9	Infections 01/2017 - 09/2006
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 04/2008
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2013
4	Systemic Scleroderma (Systemic Sclerosis) 11/2020 - 12/2002
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016 - 02/2003
3	Vasculitis (Vasculitides) 01/2016 - 12/2002
2	Rheumatic Diseases (Rheumatism) 04/2018 - 06/2015
2	Neoplasms (Cancer) 01/2016 - 09/2006
2	Takayasu Arteritis (Arteritis, Takayasu's) 01/2015 - 01/2011
2	Arthritis (Polyarthritis) 01/2010 - 04/2009
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2010 - 04/2008
2	Thrombocytopenia (Thrombopenia) 04/2009 - 01/2009
1	Diverticulum 04/2022
1	Mixed Connective Tissue Disease (MCTD) 01/2022
1	Lung Diseases (Lung Disease) 01/2017
1	Diabetes Mellitus 01/2017
1	Bronchiectasis 11/2016
1	Behcet Syndrome (Behcet's Syndrome) 01/2016
1	Necrosis 01/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2015
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2015
1	Polymyositis 01/2015
1	Arteritis 01/2015
1	Autoimmune Hepatitis 01/2015
1	Epstein-Barr Virus Infections 04/2013
1	Psychotic Disorders (Schizoaffective Disorder) 01/2013
1	Osteonecrosis (Kienbock's Disease) 01/2013
1	Adult-Onset Still's Disease 01/2012
1	Lung Neoplasms (Lung Cancer) 10/2011
1	Relapsing Polychondritis 10/2011
1	HIV Infections (HIV Infection) 04/2011
1	Lipodystrophy 04/2011
1	Churg-Strauss Syndrome (Allergic Angiitis) 02/2011
1	Subacute Thyroiditis (Thyroiditis, De Quervain) 01/2011
1	Ulcerative Colitis 01/2011
1	Graves Disease (Basedow Disease) 01/2011
1	Proteinuria 08/2010

Drug/Important Bio-Agent (IBA)

7	tocilizumab (atlizumab)FDA Link 04/2022 - 08/2010
7	Methotrexate (Mexate)FDA LinkGeneric 01/2017 - 08/2010
5	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 06/2006
4	Abatacept (Orencia)FDA Link 01/2017 - 03/2013
4	Rituximab (Mabthera)FDA Link 07/2015 - 04/2007
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2010 - 12/2002
3	Biological ProductsIBA 04/2018 - 09/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 04/2007
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 01/2011
3	SteroidsIBA 01/2016 - 04/2010
3	Polysaccharides (Glycans)IBA 12/2015 - 06/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2014 - 04/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2012 - 04/2005
2	AntibodiesIBA 01/2022 - 01/2015
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 01/2013
2	RibonucleoproteinsIBA 01/2022 - 01/2013
2	Etanercept (Enbrel)FDA Link 01/2017 - 01/2010
2	Infliximab (Remicade)FDA Link 01/2017 - 01/2016
2	Adalimumab (Humira)FDA Link 01/2017 - 01/2017
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2016 - 01/2013
2	Methylprednisolone FDA LinkGeneric 01/2016 - 04/2007
2	23-valent pneumococcal capsular polysaccharide vaccineIBA 12/2015 - 06/2015
2	GlucocorticoidsIBA 01/2013 - 01/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2010 - 12/2002
2	thiamine triphosphorate (TTP)IBA 04/2009 - 06/2008
2	DNA (Deoxyribonucleic Acid)IBA 04/2009 - 01/2009
1	HLA-DRB1*04:01 antigenIBA 01/2022
1	cyclo(Arg-Pro) (CI 4)IBA 01/2022
1	poly(dG-dA)n.poly(dC-dT)n (((GA)n))IBA 11/2020
1	sifalimumabIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	InterferonsIBA 01/2020
1	1- hydroxy- 5,8- bis(2- ((2- hydroxyethyl)amino)ethylamino)- 9,10- anthracenedioneIBA 04/2018
1	tofacitinibIBA 01/2017
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Azathioprine (Imuran)FDA LinkGeneric 01/2016
1	HLA-G Antigens (HLA G)IBA 01/2016
1	VaccinesIBA 12/2015
1	golimumab FDA Link 12/2015
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2015
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2015
1	Antirheumatic Agents (DMARD)IBA 09/2014
1	HLA-DR6 Antigen (HLA DR6 Antigen)IBA 01/2014
1	Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA 01/2014
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2013
1	SS-B antibodiesIBA 01/2013
1	AutoantibodiesIBA 01/2013
1	Interleukin-18 (Interleukin 18)IBA 01/2012
1	InterleukinsIBA 01/2012
1	Immunoglobulins (Immunoglobulin)IBA 10/2011
1	Immunoglobulin G (IgG)IBA 10/2011
1	Interleukin-5 (Interleukin 5)IBA 02/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2011
1	Phenobarbital (Luminal)FDA Link 01/2011
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2011
1	NitrogenIBA 08/2010

Therapy/Procedure

10	Therapeutics 01/2016 - 02/2002
1	Traction 11/2016